SARS and MERS: recent insights into emerging coronaviruses

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574

A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

Tg, K., Erdman, D. D., Cs, G., Zaki, Peret, T. C. T., Emery, S. L., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,353

Coronaviruses: An Overview of Their Replication and Pathogenesis

Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445

Coronavirus as a possible cause of severe acute respiratory syndrome

Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,638

Bats Are Natural Reservoirs of SARS-Like Coronaviruses

Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453

Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review

Singh, R. S., Singh, A. K., Kaur, H., Batra, G., Sarma, P., Kaur, H., Bhattacharyya, A., Sharma, A. R., Kumar, S., Upadhyay, S., et al. (2021) · Phytotherapy Research · doi:10.1002/ptr.7150 · Cited by 57

Zoonoses and global epidemics

Judson, S. D., & Rabinowitz, P. M. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000749 · Cited by 57

Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?

Nilashi, M., Samad, S., Yusuf, S. Y. M., & Akbari, E. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.05.009 · Cited by 57

Coagulation Disorders and Thrombosis in COVID-19 Patients and a Possible Mechanism Involving Endothelial Cells: A Review

Chen, A., Wang, C., Zhu, W.-L., & Chen, W. (2022) · Aging and Disease · doi:10.14336/ad.2021.0704 · Cited by 60

Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks—implications for coronavirus vaccine development

Ng, O.-W., & Tan, Y.-J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1228500 · Cited by 51

Tracking zoonotic pathogens using blood-sucking flies as 'flying syringes'

Essono, P.-Y. B., Ollomo, B., Arnathau, C., Durand, P., Mokoudoum, N. D., Mouele, L. Y., Okouga, A.-P., Boundenga, L., Mvé-Ondo, B., Obame‐Nkoghe, J., et al. (2017) · eLife · doi:10.7554/elife.22069 · Cited by 54

[Clinical Management of Lung Cancer Patients during the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)].

Xu, Y., Liu, H., Hu, K., & Wang, M. (2020) · PubMed Central · doi:10.3779/j.issn.1009-3419.2020.03.02 · Cited by 56

Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection

Campana, P., Parisi, V., Leosco, D., Bencivenga, D., Ragione, F. D., & Borriello, A. (2020) · Cells · doi:10.3390/cells9092046 · Cited by 55

COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response

Seth, S., Batra, J., & Srinivasan, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00215 · Cited by 56

An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner

Agrawal, H., Das, N., Nathani, S., Saha, S., Saini, S. K., Kakar, S. S., & Roy, P. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10048-z · Cited by 55

Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection

Huang, K., Lin, M., Kuo, T., Chen, C., Lin, C., Chou, Y., Chao, T., Pang, Y.-H., Kao, H., Huang, R., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012828 · Cited by 55

Viral infections and implications for male reproductive health

Teixeira, T. A., de Oliveira, Y. R., Bernardes, F. S., Kallas, E. G., Duarte‐Neto, A. N., Esteves, S. C., Drevet, J. R., & Hallak, J. (2021) · Asian Journal of Andrology · doi:10.4103/aja.aja_82_20 · Cited by 62

ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review

Shibeeb, S., & Khan, A. S. (2021) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2021.07.006 · Cited by 56

Consequences of COVID-19 for the Pancreas

Abramczyk, U., Nowaczyński, M., Słomczyński, A., Wojnicz, P., Zatyka, P., & Kuzan, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020864 · Cited by 52

Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods

Rafi, M. O., Al-Khafaji, K., Sarker, M. T., Taşkın‐Tok, T., Rana, A. S., & Rahman, M. S. (2022) · RSC Advances · doi:10.1039/d1ra06532g · Cited by 56

Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants

Zhang, W., Bailey-Elkin, B. A., Knaap, R. C. M., Khare, B., Dalebout, T. J., Johnson, G. G. R. J., van Kasteren, P. B., McLeish, N. J., Gu, J., He, W., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006372 · Cited by 59

A persistently infecting coronavirus in hibernating Myotis lucifugus, the North American little brown bat

Subudhi, S., Rapin, N., Bollinger, T. K., Hill, J. E., Donaldson, M. E., Davy, C. M., Warnecke, L., Turner, J. M., Kyle, C. J., Willis, C. K. R., et al. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000898 · Cited by 56

A Comparative Analysis of Factors Influencing Two Outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea

Willman, M., Kobasa, D., & Kindrachuk, J. (2019) · Viruses · doi:10.3390/v11121119 · Cited by 56

Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review

Kumar, S., Sarma, P., Kaur, H., Prajapat, M., Bhattacharyya, A., Avti, P., Sehkhar, N., Kaur, H., Bansal, S., Mahendiratta, S., et al. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101497 · Cited by 60

Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities

Wang, J. J., Edin, M. L., Zeldin, D. C., Li, C., Wang, D. W., & Chen, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107628 · Cited by 57

Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review

Crimi, E., Benincasa, G., Figueroa-Marrero, N., Galdiero, M., & Claudio Napoli, A. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.06.060 · Cited by 57

Clinical Factors Associated with Progression and Prolonged Viral Shedding in COVID-19 Patients: A Multicenter Study

Feng, Z., Li, J. S. Y., Yao, S., Yu, Q., Zhou, W., Mao, X., Li, H., Kang, W., Ouyang, X., Ji, M., et al. (2020) · Aging and Disease · doi:10.14336/ad.2020.0630 · Cited by 54

Genomic Epidemiology of the First Wave of SARS-CoV-2 in Italy

Giallonardo, F. D., Duchêne, S., Puglia, I., Curini, V., Profeta, F., Cammà, C., Marcacci, M., Calistri, P., Holmes, E. C., & Lorusso, A. (2020) · Viruses · doi:10.3390/v12121438 · Cited by 56

Exploring optimal control of epidemic spread using reinforcement learning

Ohi, A. Q., Mridha, M. F., Monowar, M. M., & Hamid, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-79147-8 · Cited by 55

A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19

Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 58

Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients

Abdollahzadeh, R., Shushizadeh, M. H., Barazandehrokh, M., Choopani, S., Azarnezhad, A., Paknahad, S., Pirhoushiaran, M., Makani, S. Z., Yeganeh, R. Z., Al-Kateb, A., et al. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105098 · Cited by 55

Potential Effects of Coronaviruses on the Liver: An Update

Wang, X., Lei, J., Li, Z., & Yan, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.651658 · Cited by 56

Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19

Islam, F., Bibi, S., Meem, A. F. K., Islam, M. M., Rahaman, M. S., Bepary, S., Rahman, M. M., Rahman, M. M., Elzaki, A. A., Kajoak, S. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312638 · Cited by 55

Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets

Kim, Y., Yu, K.-M., Koh, J., Kim, E.-H., Kim, S., Kim, E. J., Casel, M. A. B., Rollon, R., Jang, S., Song, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27717-3 · Cited by 54

Risks of viral contamination in healthcare professionals during laparoscopy in the Covid-19 pandemic

Véziant, J., Bourdel, N., & Slim, K. (2020) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2020.04.010 · Cited by 54

Pediatric SARS, H1N1, MERS, EVALI, and Now Coronavirus Disease (COVID-19) Pneumonia: What Radiologists Need to Know

Foust, A. M., Winant, A. J., Chu, C. W., Das, K. M., Phillips, G. S., & Lee, E. Y. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.23267 · Cited by 54

Estimation of the serial interval and basic reproduction number of COVID‐19 in Qom, Iran, and three other countries: A data‐driven analysis in the early phase of the outbreak

Aghaali, M., Kolifarhood, G., Nikbakht, R., Saadati, H. M., & Nazari, S. S. H. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13656 · Cited by 54

The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection

Merzon, E., Green, I., Vinker, S., Golan‐Cohen, A., Gorohovski, A., Avramovich, E., Frenkel‐Morgenstern, M., & Magen, E. (2021) · FEBS Journal · doi:10.1111/febs.15784 · Cited by 59

Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples

Biji, A., Khatun, O., Swaraj, S., Narayan, R., Rajmani, R. S., Sardar, R., Satish, D., Mehta, S., Bindhu, H., Jeevan, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103525 · Cited by 54

Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay

Aouadi, W., Eydoux, C., Coutard, B., Martin, B., Debart, F., Vasseur, J., Contreras, J. M., Morice, C., Quérat, G., Jung, M., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.06.021 · Cited by 54

Occurrence of microbial indicators, pathogenic bacteria and viruses in tropical surface waters subject to contrasting land use

Goh, S. G., Saeidi, N., Gu, X., Vergara, G. G. R. V., Liang, L., Fang, H., Kitajima, M., Kushmaro, A., & Gin, K. Y. (2018) · Water Research · doi:10.1016/j.watres.2018.11.058 · Cited by 54

Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19

Elkodous, M. A., Olojede, S. O., Morsi, M., & El-Sayyad, G. S. (2021) · RSC Advances · doi:10.1039/d1ra04835j · Cited by 55

Clinical features and sexual transmission potential of SARS-CoV-2 infected female patients: a descriptive study in Wuhan, ChinaPreprint

Cui, P., Chen, Z., Wang, T., Dai, J., Zhang, J., Ding, T., Jiang, J., Liu, J., Zhang, C., Shan, W., et al. (2020) · medRxiv · doi:10.1101/2020.02.26.20028225 · Cited by 54

Structural Similarity of SARS-CoV2 Mpro and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 TherapeuticsPreprint

Bafna, K., Krug, R. M., & Montelione, G. T. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12153615 · Cited by 54

A Questionnaire Study Effect of COVID-19 Pandemic on Anxiety and Burnout Levels in Emergency Healthcare Workers

Şahin, T., Aslaner, H., Eker, Ö. O., Gökçek, M. B., & Doğan, M. (2020) · International Journal Of Medical Science And Clinical Invention · doi:10.18535/ijmsci/v7i09.010 · Cited by 54

Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome

Zhuang, C., Kang, M., & Lee, M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.018 · Cited by 54

The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)

Mirzaei, R., Attar, A., Papizadeh, S., Jeda, A. S., Hosseini‐Fard, S. R., Jamasbi, E., Kazemi, S., Amerkani, S., Talei, G. R., Moradi, P., et al. (2021) · Archives of Virology · doi:10.1007/s00705-021-05036-8 · Cited by 59

Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning

Rajput, A., Thakur, A., Mukhopadhyay, A., Kamboj, S., Rastogi, A., Gautam, S., Jassal, H., & Kumar, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.037 · Cited by 54

Gastrointestinal Infection Could Be New Focus for Coronavirus Diagnosis

Cipriano, M., Ruberti, E., & Giacalone, A. (2020) · Cureus · doi:10.7759/cureus.7422 · Cited by 52

Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19

Lega, S., Naviglio, S., Volpi, S., & Tommasini, A. (2020) · Vaccines · doi:10.3390/vaccines8020224 · Cited by 56

Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study

Matsuzawa, Y., Ogawa, H., Kimura, K., Konishi, M., Kirigaya, J., Fukui, K., Tsukahara, K., Shimizu, H., Iwabuchi, K., Yamada, Y., et al. (2020) · Hypertension Research · doi:10.1038/s41440-020-00535-8 · Cited by 52

Preventing the development of severe COVID-19 by modifying immunothrombosis

Morris, G., Bortolasci, C. C., Puri, B. K., OLIVE, L. S., Marx, W., O'Neil, A. E., Athan, E., Carvalho, A. F., Maes, M. H. J., Walder, K. R., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118617 · Cited by 51

Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review

Viswanathan, V., Puvvula, A., Jamthikar, A. D., Saba, L., Johri, A. M., Kotsis, V., Khanna, N. N., Dhanjil, S. K., Majhail, M., Misra, D. P., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i3.215 · Cited by 53

Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19

Kiener, M., Roldán, N., Machahua, C., Sengupta, A., Geiser, T., Guenat, O. T., Funke-Chambour, M., Hobi, N., & Julio, M. K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.644678 · Cited by 52

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses

Ye, C., Chiem, K., Park, J., Silvas, J. A., Vasquez, D. M., Sourimant, J., Lin, M. J., Greninger, A. L., Plemper, R. K., Torrelles, J. B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111593118 · Cited by 52

Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome

Nye, S., Whitley, R. J., & Kong, M. Y. F. (2016) · Frontiers in Pediatrics · doi:10.3389/fped.2016.00128 · Cited by 51

The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection

Takano, T., Endoh, M., Fukatsu, H., Sakurada, H., Doki, T., & Hohdatsu, T. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.07.022 · Cited by 52

Vitamin D3 as Potential Treatment Adjuncts for COVID-19

Malaguarnera, L. (2020) · Nutrients · doi:10.3390/nu12113512 · Cited by 54

Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV)Preprint

Huang, Q., & Herrmann, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.01.930537 · Cited by 54

Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans

Srivastava, R., Daulatabad, S. V., Srivastava, M., & Janga, S. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197090 · Cited by 52

SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime

Domingues, R., Lippi, A., Setz, C., Outeiro, T. F., & Kriško, A. (2020) · Aging · doi:10.18632/aging.103989 · Cited by 52

Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins—An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic

Yu, M., Zhang, T., Zhang, W., Sun, Q., Li, H., & Li, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.628551 · Cited by 52

DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: A meta-analysis

Yang, Y., Cai, Z., & Zhang, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251916 · Cited by 49

Cellular RNA Helicase DDX1 Is Involved in Transmissible Gastroenteritis Virus nsp14-Induced Interferon-Beta Production

Zhou, Y., Wu, W., Xie, L., Wang, D., Ke, Q., Hou, Z., Wu, X., Fang, Y., Chen, H., Xiao, S., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00940 · Cited by 51

Epidemiology of CoViD-19 Pandemic: Recovery and mortality ratio around the globe

Noor, A. U., Maqbool, F., Bhatti, Z. A., & Khan, A. U. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.covid19-s4.2660 · Cited by 51

Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape

Nel, A. E., & Miller, J. F. (2021) · ACS Nano · doi:10.1021/acsnano.1c01845 · Cited by 50

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques

Prescott, J. B., Falzarano, D., de Wit, E., Hardcastle, K., Feldmann, F., Haddock, E., Scott, D. P., Feldmann, H., & Munster, V. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00205 · Cited by 50

Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation

Cardone, M., Yano, M., Rosenberg, A. S., & Puig, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01131 · Cited by 49

Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection

Ansari, A., Arya, R. K., Sachan, S., Jha, S. N., Kalia, A., Lall, A., Sette, A., Grifoni, A., Weiskopf, D., Coshic, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636768 · Cited by 50

Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn

Shahgolzari, M., Yavari, A., Arjeini, Y., Miri, S. M., Darabi, A., Nejad, A. S. M., & Keshavarz, M. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101417 · Cited by 50

Airborne transmission of biological agents within the indoor built environment: a multidisciplinary review

Argyropoulos, C. D., Skoulou, V. K., Efthimiou, G., & Michopoulos, A. K. (2022) · Air Quality Atmosphere & Health · doi:10.1007/s11869-022-01286-w · Cited by 56

A novel cartridge for nucleic acid extraction, amplification and detection of infectious disease pathogens with the help of magnetic nanoparticles

Fang, Y., Wang, Y., Zhu, L., Liu, H., Su, X., Liu, Y., Zhu, C., Chen, H., & He, N. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.108092 · Cited by 50

Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study

Wakchaure, P. D., Ghosh, S. K., & Ganguly, B. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c06747 · Cited by 50

Cryo-electron Microscopy Structure of S-Trimer, a Subunit Vaccine Candidate for COVID-19

Ma, J., Su, D., Sun, Y., Huang, X., Liang, Y. S., Fang, L., Ma, Y., Li, W., Liang, P., & Zheng, S. (2021) · Journal of Virology · doi:10.1128/jvi.00194-21 · Cited by 47

Neurological Damage by Coronaviruses: A Catastrophe in the Queue!

Mishra, R., & Banerjea, A. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565521 · Cited by 49

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies

Molaei, S., Dadkhah, M., Asghariazar, V., Karami, C., & Safarzadeh, E. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107051 · Cited by 50

Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity

Resnick, S. J., Iketani, S., Hong, S. J., Zask, A., Liu, H., Kim, S. S., Melore, S. M., Lin, F.-Y., Nair, M. S., Huang, Y., et al. (2021) · Journal of Virology · doi:10.1128/jvi.02374-20 · Cited by 49

The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis

Wu, K.-S., Lin, P., Chen, Y.-S., Pan, T.-C., & Tang, P. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1933165 · Cited by 49

Kidney injury in COVID-19 patients, drug development and their renal complications: Review study

Yarijani, Z. M., & Najafi, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111966 · Cited by 52

An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era

Pascual‐Iglesias, A., Cantón, J., Ortega‐Prieto, A. M., Jiménez-Guardeño, J. M., & Regla-Nava, J. Á. (2021) · Pathogens · doi:10.3390/pathogens10081030 · Cited by 50

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection

Moga, E., Lynton‐Pons, E., & Domingo, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904686 · Cited by 48

Profile analysis of circRNAs induced by porcine endemic diarrhea virus infection in porcine intestinal epithelial cells

Chen, J., Wang, H., Jin, L., Wang, L., Huang, X., Chen, W., Yan, M., & Liu, G. (2018) · Virology · doi:10.1016/j.virol.2018.11.014 · Cited by 49

Factors Influencing Global Variations in COVID-19 Cases and Fatalities; A Review

Abu-Hammad, O. A., Alnazzawi, A. A., Borzangy, S., Abu-Hammad, A., Fayad, M. I., Saadaledin, S., Abu‐Hammad, S., & Dar-Odeh, N. S. (2020) · Healthcare · doi:10.3390/healthcare8030216 · Cited by 48

The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2

Jin, Z., Wang, H., Duan, Y., & Yang, H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.091 · Cited by 48

Zoonotic spill-over of SARS-CoV-2: mink-adapted virus in humans

Rąbalski, Ł., Kosiński, M., Mazur-Panasiuk, N., Szewczyk, B., Bieńkowska-Szewczyk, K., Kant, R., Sironen, T. A., Pyrć, K., & Grzybek, M. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.12.001 · Cited by 49

Mathematical Analysis of a COVID-19 Epidemic Model by Using Data Driven Epidemiological Parameters of Diseases Spread in India

Pal, D., Ghosh, D., Santra, P. K., & Mahapatra, G. S. (2022) · BIOPHYSICS · doi:10.1134/s0006350922020154 · Cited by 51

Drug Repurposing Screens Reveal FDA Approved Drugs Active Against SARS-CoV-2Preprint

Dittmar, M., Lee, J. S., Whig, K., Segrist, E., Li, M., Jurado, K. A., Samby, K., Ramage, H. R., Schultz, D., & Cherry, S. R. (2020) · SSRN Electronic Journal · doi:10.1101/2020.06.19.161042 · Cited by 49

Angiotensin‐converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection

Tan, H. W., Xu, Y., & Lau, A. T. Y. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2122 · Cited by 47

Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach

van Tol, S., Mögling, R., Li, W., Godeke, G.-J., Swart, A., Bergmans, B., Brandenburg, A. H., Kremer, K., Murk, J., van Beek, J., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1813636 · Cited by 46

Estimation of novel coronavirus ( COVID ‐19) reproduction number and case fatality rate: A systematic review and meta‐analysis

Ahammed, T., Anjum, A., Rahman, M. M., Haider, N., Kock, R. A., & Uddin, M. J. (2021) · Health Science Reports · doi:10.1002/hsr2.274 · Cited by 48

An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies

Farooqi, T., Malik, J. A., Mulla, A. H., Hagbani, T. A., Almansour, K., Ubaid, M. A., Alghamdi, S., & Anwar, S. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.08.014 · Cited by 49

Cross-species transmission, evolution and zoonotic potential of coronaviruses

Li, Q., Shah, T., Wang, B., Qu, L., Wang, R., Hou, Y., Baloch, Z., & Xia, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1081370 · Cited by 46

Establishment and Application of a Universal Coronavirus Screening Method Using MALDI-TOF Mass Spectrometry

Xiu, L., Zhang, C., Wú, Z., & Peng, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01510 · Cited by 48

Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

Beeraka, N. M., Sadhu, S. P., Madhunapantula, S. V., Pragada, R. R., Svistunov, A. А., Nikolenko, V. N., Михалева, Л. М., & Aliev, G. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.552925 · Cited by 47

Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis

Quan, C., Li, C., Ma, H., Li, Y., & Zhang, H. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-20 · Cited by 49

Efficacy of canakinumab in mild or severe COVID‐19 pneumonia

Falasca, K., Penta, M. D., Ucciferri, C., Auricchio, A., Nicola, M. D., Marchioni, M., Celletti, E., Sabatini, E., Cipollone, F., & Vecchiet, J. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.400 · Cited by 48

Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients

Raghav, A., Khan, Z. A., Upadhayay, V. K., Tripathi, P., Gautam, K. A., Mishra, B. K., Ahmad, J., & Jeong, G. (2021) · Cells · doi:10.3390/cells10030587 · Cited by 48

Cadaveric Simulation of Endoscopic Endonasal Procedures: Analysis of Droplet Splatter Patterns During the COVID‐19 Pandemic

Sharma, D., Rubel, K. E., Ye, M. J., Shipchandler, T. Z., Wu, A. W., Higgins, T. S., Burgin, S. J. M., Ting, J. Y., & Illing, E. A. (2020) · Otolaryngology · doi:10.1177/0194599820929274 · Cited by 47

Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury

Du, J., Li, H., Lian, J., Zhu, X., Qiao, L., & Lin, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01699-3 · Cited by 48

Early-onset symptomatic neonatal COVID-19 infection with high probability of vertical transmission

Kulkarni, R., Rajput, U. C., Dawre, R. M., Valvi, C., Nagpal, R., Magdum, N., Vankar, H., Sonkawade, N., Das, A., Vartak, S., et al. (2020) · Infection · doi:10.1007/s15010-020-01493-6 · Cited by 47

Genetic and Pathogenic Characterization of SARS-CoV-2: A Review

Bahrami, A., & Ferns, G. A. (2020) · Future Virology · doi:10.2217/fvl-2020-0129 · Cited by 49

T and B cell Epitope analysis of SARS‐CoV‐2 S protein based on immunoinformatics and experimental research

Chen, Z., Ruan, P., Wang, L., Nie, X., Ma, X., & Tan, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16200 · Cited by 47

Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19

Morenikeji, O. B., Bernard, K., Strutton, E. A., Wallace, M., & Thomas, B. N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.582953 · Cited by 46

Human Coronaviruses: General Features

Li, X., Luk, H. K. H., Lau, S. K. P., & Woo, P. C. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95704-0 · Cited by 47

The African swine fever virus protease pS273R inhibits DNA sensing cGAS-STING pathway by targeting IKKε

Luo, J., Ni, J., Jiang, S., Xia, N., Guo, Y., Shao, Q., Zhang, J., Cao, Q., Xu, Z., Zheng, W., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2065962 · Cited by 47

Emerging Coronaviruses: Severe Acute Respiratory Syndrome ( SARS ) and Middle East Respiratory Syndrome (MERS)

Sisk, J. M., & Frieman, M. B. (2015) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0004025.pub3 · Cited by 2

The lessons of COVID-19, SARS, and MERS: Implications for preventive strategies

Semenova, Y. M., Trenina, V., Pivina, L. M., Glushkova, N., Е.Т., Ж., Ospanov, E., & Bjørklund, G. (2022) · International Journal of Healthcare Management · doi:10.1080/20479700.2022.2051126 · Cited by 13

Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) (Coronaviridae)

Peiris, M. J. S., & Poon, L. L. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814515-9.00138-7 · Cited by 30

Challenges presented by MERS corona virus, and SARS corona virus to global health

Al-Hazmi, A. (2016) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2016.02.019 · Cited by 92

A decade after SARS: strategies for controlling emerging coronaviruses

Graham, R. L., Donaldson, E., & Baric, R. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3143 · Cited by 689